New Findings from University of Nevada Describe Advances in Business Ethics (The Use of Genetic Testing Information In the Insurance Industry: an Ethical and Societal Analysis of Public Policy Options)

2019 JUN 07 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Investigators publish new report on Business - Business Ethics. According to news originating from Las Vegas, United States, by NewsRx correspondents, research stated, “Informed by a search of the literature about the usage of genetic testing information (GTI) by insurance companies, this paper presents a practical ethical analysis of several distinct public policy options that might be used to govern or constrain GTI usage by insurance providers. As medical research advances and the extension to the Human Genome Project (2016, https://en.wikipedia.org/wiki/Human_Genome_Project_-_Write) moves to its fullness over the next decade, such research efforts will allow the full synthesis of human DNA to be connected to predictive health dispositions.”

Our news journalists obtained a quote from the research from the University of Nevada, “As testing costs fall, there will be ever more pressure for citizens to disclose GTI. Genetic testing information is integral to future medical care because it can be used to better assess individually tailored medical therapies as well as to allow a more informed risk analysis by the insurance industry, which in some countries such as the USA underwrites a majority of citizen medical expenses. As discussed in this examination, the revelation of people’s uniquely personal GTI to insurers has enormous societal implications. The major contribution of the paper is to offer policy makers and concerned citizens a nuanced articulation of the basic options to regulate GTI, with a special consideration for ethical fairness and equity. As genetic-based medicine blossoms and pressures to reduce healthcare costs increase, there will be an ever greater impetus for countries to revisit their genetic testing policies.”

According to the news editors, the research concluded: “Organizations and policy makers striving to create GTI oversights perceived to be both fair and effective need to be aware of the ethical perspectives discussed in this paper.”

For more information on this research see: The Use of Genetic Testing Information In the Insurance Industry: an Ethical and Societal Analysis of Public Policy Options. Journal of Business Ethics, 2019;156(1):105-121. Journal of Business Ethics can be contacted at: Springer, Van Godewijckstraat 30, 3311 Gz Dordrecht, Netherlands. (Springer - www.springer.com; Journal of Business Ethics - http://www.springerlink.com/content/0167-4544/)

The news correspondents report that additional information may be obtained from A. Nill, University of Nevada, Lee Business Sch, Dept Mkt & Int Business, Las Vegas, NV 89154, United States. Additional authors for this research include G. Laczniak and P. Thistle.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1007/s10551-017-3554-y. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)